TFB Advisors LLC

Position in LLY — ELI LILLY & Co

CIK 1965201 OVERLAND PARK, KS

Position in LLY

as of Jun 30, 2026 · filed Aug 6, 2026 Compact

Position Value

$978,734

+$225,443 QoQ

Shares Held

816

-0.4% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

1.00%

of 13F equity value

Holder Rank

#3,165

of 4,605 holders

Holding Since

Dec 2022

14 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

TFB Advisors LLC holds $3,025,209 across 5 Drug Manufacturers - General names. LLY ranks #1 (32.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co This page	816	$978,734
2	AMGN	Amgen Inc	2,335	$845,550
3	BIIB	Biogen Inc.	2,424	$523,729
4	MRK	Merck & Co., Inc.	2,814	$361,599
5	GILD	Gilead Sciences, Inc.	2,498	$315,597

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$978,734	816	-0.4%	Shares	Sole	2026-08-06
2026-03-31	$753,291	819	-17.1%	Shares	Sole	2026-04-20
2025-12-31	$1,061,783	988	-1.0%	Shares	Sole	2026-02-13
2025-09-30	$761,474	998	-40.3%	Shares	Sole	2025-11-04
2025-06-30	$1,302,594	1,671	-4.9%	Shares	Sole	2025-07-30
2025-03-31	$1,451,123	1,757	+3.0%	Shares	Sole	2025-05-14
2024-12-31	$1,316,260	1,705	-13.8%	Shares	Sole	2025-01-29
2024-09-30	$1,751,503	1,977	+2.4%	Shares	Sole	2024-10-31
2024-06-30	$1,748,288	1,931	+10.7%	Shares	Sole	2024-07-30
2024-03-31	$1,356,762	1,744	+93.8%	Shares	Sole	2024-05-03
2023-12-31	$524,627	900	-1.5%	Shares	Sole	2024-01-18
2023-06-30	$428,647	914	+13.7%	Shares	Sole	2023-07-18
2023-03-31	$276,109	804	+5.8%	Shares	Sole	2023-04-10
2022-12-31	$278,038	760	—	Shares	Sole	2023-02-15
No filing history on record for this holder in this stock.